How Comprehensive Master Data Can Help Pharma Companies Expand DSCSA Pharma Supply Chain Compliance

New software evolves from VRS utility to compliance-as-a-service platform for pharmaceutical manufacturers, wholesalers, pharmacies.

'Master data integrity is the backbone for the pharmaceutical supply chain,' says Spherity Inc.’s CEO, Dr. Michael Rüther.
"Master data integrity is the backbone for the pharmaceutical supply chain," says Spherity Inc.’s CEO, Dr. Michael Rüther.
Spherity

Key Takeaways:

·      As the industry faces stricter enforcement of the Drug Supply Chain Security Act, companies are struggling with fragmented data and manual verification processes.

·      CARO v1.3 will work to consolidate regulatory workflows into a single, high-integrity platform.

·      It offers a protected environment for requesting information and exchanging sensitive DSCSA-related documents with full audit trails.

Spherity, a global software provider specializing in secure and decentralized identity management solutions, announces a major upgrade to its DSCSA Compliance Software, CARO. The launch of version 1.3 marks a strategic evolution of the CARO platform from a service provider utility into the industry’s comprehensive Authorized Trading Partner (ATP) Master Data and Communication Platform, purpose-built for regulatory compliance across the U.S. pharma supply chain. This comes as the industry faces stricter enforcement of the Drug Supply Chain Security Act (DSCSA).

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026